Saqib Islam
Independent DirectorMr. Saqib Islam, J.D. had been Chief Executive Officer and Director at SpringWorks Therapeutics, Inc. since August 2018 until July 01, 2025. He served as an Independent Director of Passage Bio, Inc. since March 2019 until September 16, 2025. He has been Chief Executive Officer and Director at Beeline Medicines Corporation. Mr. Islam served as Chief Business Officer of Moderna Therapeutics, Inc. since February 2016 until August 2017. He serves as an Independent Director at ARS Pharmaceuticals Inc since November 08, 2022. He served as Chief Financial Officer & Chief Business Officer of SpringWorks Therapeutics, Inc. from August 2017 to August 2018. Mr. Islam served as the Chief Strategy & Portfolio Officer of Alexion Pharmaceuticals, Inc. from April 2013 to April 1, 2016 and its Executive Vice President from February 2013 to February 2016. Mr. Islam served as Independent Director at ARYA Sciences Acquisition Corp III since August 2020 until November 2021. Mr. Islam served as Senior Vice President of Alexion Pharmaceuticals, Inc., from April 2013 to February 2015. He served as a Managing Director of Morgan Stanley since December 2005. He is a Director of Silverback Therapeutics, Inc. since July 2017. Mr. Islam has an extensive background in the healthcare banking sector, having held positions of increasing responsibility in the investment banking divisions of Merrill Lynch and most recently, Credit Suisse Securities, where he served as Managing Director, Head of Healthcare and Diversified Industrials Capital Markets. Mr. Islam provided strategic analysis and advice to client firms across diverse industry segments. Mr. Islam received his B.A. in Communications from McGill University, where he was a Faculty and University Scholar and his J.D. from Columbia Law School, where he was a Harlan Fiske Scholar.
Positions
- Company NameARS Pharmaceuticals, Inc.Stock CodeSPRYPositionIndependent DirectorColleagues
- JCJustin ChakmaChief Business Officer
- PSPratik ShahChairman of the Board
- DCDonn CasaleCEO, President & Director
- RBRobert BellCo-Founder & Chief Science Officer
- KDKathleen D. ScottChief Financial Officer
- BTBrian T. DorseyChief Operating Officer
- PKPeter KolchinskyIndependent Director
- PMPhillip M. SchneiderIndependent Director
